Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have been given an average recommendation of “Hold” by the twenty analysts that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and ten have issued a buy recommendation on the company. The average 1 year price objective among brokers that have covered the stock in the last year is €88.39 ($105.22).

Several brokerages have weighed in on FME. Berenberg Bank set a €95.60 ($113.81) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Tuesday. Citigroup Inc. set a €92.00 ($109.52) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Tuesday, August 8th. J P Morgan Chase & Co set a €95.10 ($113.21) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Tuesday, August 8th. Goldman Sachs Group, Inc. (The) set a €97.00 ($115.48) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Tuesday, August 8th. Finally, Deutsche Bank AG set a €84.00 ($100.00) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Tuesday, August 8th.

WARNING: “Fresenius Medical Care AG & Co. KGaA (FME) Receives Average Recommendation of “Hold” from Analysts” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/09/fresenius-medical-care-ag-co-kgaa-fme-receives-average-recommendation-of-hold-from-analysts.html.

Shares of Fresenius Medical Care AG & Co. KGaA (FME) traded down 0.740% on Friday, reaching €79.376. 127 shares of the company were exchanged. The stock has a 50 day moving average of €79.27 and a 200-day moving average of €81.47. The company has a market capitalization of €24.36 billion and a P/E ratio of 20.468. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €70.82 and a 52-week high of €89.07.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.